Form 8-K - Current report:
SEC Accession No. 0001104659-25-050715
Filing Date
2025-05-20
Accepted
2025-05-20 06:35:21
Documents
15
Period of Report
2025-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515452d1_8k.htm   iXBRL 8-K 28659
2 EXHIBIT 99.1 tm2515452d1_ex99-1.htm EX-99.1 23305
3 GRAPHIC tm2515452d1_ex99-1img01.jpg GRAPHIC 3046
4 GRAPHIC tm2515452d1_ex99-1img02.jpg GRAPHIC 18589
  Complete submission text file 0001104659-25-050715.txt   257479

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA zura-20250520.xsd EX-101.SCH 3011
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250520_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250520_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2515452d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25966109
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)